써모 피셔 사이언티픽
시가총액
$216.5B
글로벌 순위
#71
역대 최고치
$244.9B
2021-12-31
총 성장률
+0%
2026년 이후
Market Cap Context
- Larger than 81% of the 367 companies we track (globally).
- Equivalent to 0.7% of United States's GDP (2025 data).
- Just above: #70 CrowdStrike Holdings, Inc. ($217.8B)
- Just below: #72 IBM ($215.6B)
- Best year: 2000 (+98%). Worst year: 1998 (-62%).
써모 피셔 사이언티픽 Financial Breakdown (FY 2025)
Source: Yahoo Finance — TMO annual filings (2025) →$44.6B revenue · $8.1B operating income · $6.7B net income
- ●Operating margin: 18.2% on $44.6B in revenue.
- ●R&D is 3.1% of revenue ($1.4B).
- ●Net income margin: 15.0% — $6.7B in profit.
- ●Free cash flow: $6.3B (14.1% of revenue).
Cost / Operating Expenses
Total operating expenses $36.4B
Total
$36.4B
Capital Expenditures
$1.5B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$6.3B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
써모 피셔 사이언티픽 소개
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).
써모 피셔 사이언티픽 시가총액 추이 (2026–2026)
써모 피셔 사이언티픽 vs Sector Peers by Market Cap
써모 피셔 사이언티픽 비교
순위 추이
| 연도 | 시가총액 | 순위 | 전년 대비 변화 |
|---|---|---|---|
| 2026 | $216.5B | #71(↓9) | +0.7% |
| 2025 | $215.0B | #62(↓9) | +11.8% |
| 2024 | $192.3B | #53(↓4) | -1.7% |
| 2023 | $195.7B | #49(↓12) | -3.4% |
| 2022 | $202.5B | #37(↓6) | -17.3% |
| 2021 | $244.9B | #31(↑8) | +43.5% |
| 2020 | $170.6B | #39(↑16) | +43.7% |
| 2019 | $118.7B | #55(↑4) | +45.6% |
| 2018 | $81.5B | #59(↑12) | +18.2% |
| 2017 | $69.0B | #71(↑17) | +35.1% |
| 2016 | $51.1B | #88(↓14) | -0.1% |
| 2015 | $51.1B | #74(↑11) | +13.8% |
| 2014 | $44.9B | #85(↓4) | +13.1% |
| 2013 | $39.7B | #81(↑35) | +75.9% |
| 2012 | $22.6B | #116(↑16) | +42.8% |
| 2011 | $15.8B | #132(↓10) | -18.8% |
| 2010 | $19.5B | #122(↓2) | +16.1% |
| 2009 | $16.8B | #120(↓3) | +40.0% |
| 2008 | $12.0B | #117(↓9) | -40.9% |
| 2007 | $20.3B | #108(↑16) | +27.4% |
| 2006 | $15.9B | #124(↑21) | +50.3% |
| 2005 | $10.6B | #145(↓24) | -0.2% |
| 2004 | $10.6B | #121(↓4) | +19.8% |
| 2003 | $8.9B | #117(↓4) | +25.2% |
| 2002 | $7.1B | #113(↓1) | -15.7% |
| 2001 | $8.4B | #112(↓6) | -6.8% |
| 2000 | $9.0B | #106(↑12) | +98.3% |
| 1999 | $4.5B | #118(↓23) | -11.4% |
| 1998 | $5.1B | #95(↓53) | -61.5% |
| 1997 | $13.3B | #42(↓4) | +6.7% |
| 1996 | $12.5B | #38(↓3) | +19.0% |
| 1995 | $10.5B | #35 | +73.8% |
| 1994 | $6.0B | #35 |
기타 헬스케어 기업
자주 묻는 질문
What is Thermo Fisher Scientific Inc.'s market cap?
Thermo Fisher Scientific Inc. (TMO) has a market capitalization of $216.5B, making it the #71 largest company in the world by market cap.
What was Thermo Fisher Scientific Inc.'s highest market cap?
Thermo Fisher Scientific Inc.'s all-time high market cap was $244.9B, reached in 2021-12-31. Its highest rank was #31 in 2021.
What sector is Thermo Fisher Scientific Inc. in?
Thermo Fisher Scientific Inc. is in the Healthcare sector, specifically the Diagnostics & Research industry. It is based in United States.
How has Thermo Fisher Scientific Inc.'s market cap changed over time?
Thermo Fisher Scientific Inc. has been tracked since 2026. Its market cap has grown by 0% from $216.5B in 2026 to $216.5B today.